Trending...
- Templeton Global Income Fund Announces Update on Investment Adviser Transition to Saba Capital
- LI-CYCLE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Li-Cycle To Contact Him Directly To Discuss Their Options
- Hustle and Threads Unveils a Collection of Inspiring Goods to Ignite Entrepreneurial Spirits
NEW YORK, Nov. 21, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns whether Treace and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On November 15, 2022, Culper Research published a short report on Treace (the "Culper Report"). The Culper Report expressed the "view that Treace's primary innovation has not been in any sort of medical advancements, but in aggressive reimbursement practices and deceptive DTC marketing," which the Culper Report described "as problematic and self-defeating, as insurers appear to have begun placing Lapiplasty procedure reimbursements under scrutiny while customer complaints about misleading claims from Treace are mounting."
More on Nyenta.com
On this news, Treace's stock price fell $3.57 per share, or 14.81%, to close at $20.54 per share on November 15, 2022.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980
SOURCE Pomerantz LLP
The investigation concerns whether Treace and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On November 15, 2022, Culper Research published a short report on Treace (the "Culper Report"). The Culper Report expressed the "view that Treace's primary innovation has not been in any sort of medical advancements, but in aggressive reimbursement practices and deceptive DTC marketing," which the Culper Report described "as problematic and self-defeating, as insurers appear to have begun placing Lapiplasty procedure reimbursements under scrutiny while customer complaints about misleading claims from Treace are mounting."
More on Nyenta.com
- DellaRatta, Van Zandt, Maté, Hedges and other big names WIN BIG at Jazz for Peace Comedy NFT Awards!
- Kasuri Hosts Launch Of Bespoke Jewelry Line By Hudson Based Trans Artist
- New York Junior League Announces its 2024 Outstanding Sustainers and Outstanding Volunteers to Be
- Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Dollar General Corporation (DG) Investors
- Rochester: Updates on Pulaski Building Fire
On this news, Treace's stock price fell $3.57 per share, or 14.81%, to close at $20.54 per share on November 15, 2022.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980
SOURCE Pomerantz LLP
Filed Under: Business
0 Comments
Latest on Nyenta.com
- Driven Brands to Participate in the Morgan Stanley Global Consumer & Retail Conference
- Aperiam Bio emerges from stealth with $9 million to deliver streamlined and enhanced protein solutions
- Computational Fluid Dynamics (CFD) Market size in APAC to grow by USD 291.19 million from 2022 to 2027, Increasing M&A to drive growth - Technavio
- Advcash adds instant Pix payments in Brazil
- Mobile Power Generation Equipment Rentals Market to increase by USD 629.21 million during 2022-2027 | Increasing infrastructural activities to drive the growth - Technavio
- Floris United Methodist Church announces first-ever mission trip for people with disabilities
- Rochester: – Edgerton R-Center Model Railroad Delivers Holiday Cheer During Special December Hours
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sweetgreen, Inc. - SG
- DOLLAR GENERAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Dollar General Corporation and Encourages Investors to Contact the Firm
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Rockley Photonics Holdings Limited - RKLY; RKLY.W
- Sip Social Co. Partners With Omnify To Streamline User Experience Across Growing Operations
- AmatoMartin Strengthens Market Presence with Acquisition of Valpak Increasing Capabilities Across Mailboxes and Digital Platforms
- Gary Cross of Maher Terminals named 2024 Person of the Year by the NYNJFFFBA
- New Rochelle: Free 2 Hour Holiday Parking December 1-31
- Fred Nassiri Relaunches "Love Sees No Colour"
- A Culinary Haven in Little Caribbean, Brooklyn, Captures Hearts and Palates
- New Book 'The Kelsey Outrage' by Alison Hubbard Launching January 25th, 2024
- The Dog Gurus Bring Light to Mysterious Respiratory Illness in Dogs
- Sphere To Feature First-Of-Its-Kind Exosphere Activation With The Radio City Rockettes This Holiday Season
- Miss Grass Launches "Faces Of Cannabis" to Dismantle Harmful Stereotypes of the Cannabis Community